In spite of all the advances in pharmaceuticals and medical devices, 300,000 patients in the U.S. die every year from end stage heart failure and 250,000 heart failure patients lack a viable treatment option.
NeoCardial Technologies™ is dedicated to helping this underserved patient group lead a normal, healthy and long life.
Introducing eHeart™ designed to offer new treatment options for patients with chronic heart failure who are no longer responding to standard medical care.
NeoCardial Technologies, LLC
2400 North 2nd Street, Suite 200, Minneapolis, Minnesota 55411
Investigation device. Not available for sale in any geography.
Neocardial Technologies, LLC